Literature DB >> 16293528

The E/e filling index and right ventricular pressure in relation to applied international Doppler recommendations of left ventricular filling assessment.

Cecilia Wallentin Guron1, Odd Bech-Hanssen, Ronny Wikh, Annika Rosengren, Marianne Hartford, Kenneth Caidahl.   

Abstract

AIM: A ratio>15 between the early diastolic pulsed Doppler velocities of the mitral inflow (E) and the basal left ventricular (LV) tissue (e) has been demonstrated to predict an elevated LV filling pressure (FP). An elevated LVFP implies an elevated right ventricular pressure (RVp). In order to investigate the sensitivity of the E/e filling index, we compared E/e and RVp, in their ability to identify a Doppler-assumed elevation of LVFP. METHODS AND
RESULTS: Application of pulsed Doppler international recommendations grouped 134 patients with acute coronary syndromes (ACS) and 50 age- and sex-matched controls, according to LV filling: normal; delayed relaxation; an isolated pathological mitral-pulmonary venous-A-wave-duration difference; pseudo normal; or a restrictive filling pattern. An E/e>15 and an RVp>30 mmHg showed the following (%) sensitivity (32/94), specificity (95/76), positive (68/59), and negative (80/97) predictive values of a Doppler-assumed elevation of LVFP, in terms of either a pseudo normal or a restrictive filling pattern.
CONCLUSION: The low sensitivity of E/e to detect a Doppler-assumed elevation of LVFP could limit its clinical usefulness as a single variable, in ACS. The high sensitivity and negative predictive value of RVp support its use as an additional LV filling variable in these patients.

Entities:  

Mesh:

Year:  2005        PMID: 16293528     DOI: 10.1016/j.euje.2005.01.005

Source DB:  PubMed          Journal:  Eur J Echocardiogr        ISSN: 1532-2114


  1 in total

1.  Two-dimensional echocardiography in the assessment of long-term prognosis in patients with pulmonary arterial hypertension.

Authors:  Ling-yue Sun; Hang Zhao; Yu Kang; Xue-dong Shen; Zong-ye Cai; Jie-yan Shen; Ben He; Cheng-de Yang
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.